These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32665894)

  • 1. A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs.
    Tekade AR; Yadav JN
    Adv Pharm Bull; 2020 Jul; 10(3):359-369. PubMed ID: 32665894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers.
    Van Duong T; Van den Mooter G
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1583-1594. PubMed ID: 27321133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insoluble Polymers in Solid Dispersions for Improving Bioavailability of Poorly Water-Soluble Drugs.
    Tran TTD; Tran PHL
    Polymers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.
    Van Duong T; Van den Mooter G
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1681-1694. PubMed ID: 27267583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
    Huang BB; Liu DX; Liu K; Wu G
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
    Tran CTM; Tran PHL; Tran TTD
    Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.
    Bennett RC; Brough C; Miller DA; O'Donnell KP; Keen JM; Hughey JR; Williams RO; McGinity JW
    Drug Dev Ind Pharm; 2015 Mar; 41(3):382-97. PubMed ID: 24329130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
    Tran TTD; Tran PHL
    Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.
    Frank DS; Matzger AJ
    Mol Pharm; 2019 Feb; 16(2):682-688. PubMed ID: 30645134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
    Kumar S; Gupta SK
    Arch Pharm Res; 2014 Mar; 37(3):340-51. PubMed ID: 23674128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.